Cara Therapeutics (CARA)
(Delayed Data from NSDQ)
$0.31 USD
+0.02 (7.94%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $0.31 0.00 (0.42%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.25 |
EPS Last Quarter | -0.37 |
Last EPS Surprise | -27.59% |
ABR | 2.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.24 |
Next Year | -0.74 |
EPS (TTM) | -2.04 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.62M | 1.60M | 6.63M | 6.42M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 2.95M | 2.97M | 9.94M | 12.55M |
Low Estimate | 0.90M | 0.80M | 4.80M | 3.12M |
Year ago Sales | 4.87M | 3.00M | 20.97M | 6.63M |
Year over Year Growth Est. | -66.82% | -46.80% | -68.40% | -3.06% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.25 | -0.18 | -1.24 | -0.74 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.23 | -0.10 | -1.12 | -0.34 |
High Estimate | -0.23 | -0.10 | -1.12 | -0.34 |
Low Estimate | -0.26 | -0.25 | -1.35 | -1.13 |
Year ago EPS | -0.52 | -0.59 | -2.19 | -1.24 |
Year over Year Growth Est. | 51.92% | 69.49% | 43.38% | 40.32% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.25 | -0.18 | -1.24 | -0.74 |
7 Days Ago | -0.25 | -0.18 | -1.24 | -0.74 |
30 Days Ago | -0.25 | -0.18 | -1.24 | -0.74 |
60 Days Ago | -0.25 | -0.18 | -1.24 | -0.74 |
90 Days Ago | -0.25 | -0.18 | -1.24 | -0.74 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.25 | -0.18 | -1.24 | -0.74 |
Zacks Consensus Estimate | -0.25 | -0.18 | -1.24 | -0.74 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.37 | -0.56 | -0.59 | -0.52 | NA |
Estimate | -0.29 | -0.38 | -0.57 | -0.53 | NA |
Difference | -0.08 | -0.18 | -0.02 | 0.01 | -0.07 |
Surprise | -27.59% | -47.37% | -3.51% | 1.89% | -19.15% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more